Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Nizeng Formula for Chronic Atrophic Gastritis
NCT06324825Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Fuzheng Nizeng Formula in chronic atrophic gastritis (CAG) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Recovery rate of Low-grade Intraepithelial Neoplasia at 180 days. Started Oct 2022; status: recruiting.
02
Drugs
Fuzheng Nizeng Formula
03
Conditions
chronic atrophic gastritis (CAG)
Beyond the preview
Go deeper on NCT06324825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06324825.